SCHEMBL32688310

SCHEMBL32688310

N#Cc1c(-c2cccc(N3CCCCC3)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRK6 P43250 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ OTUD7B Q6GQQ9 2/20 0.35
▸ USP30 Q70CQ3 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HSD11B1 P28845 3/20 0.34
▸ KISS1R Q969F8 4/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KDM5B Q9UGL1 1/20 0.33
▸ IKBKB O14920 1/20 0.32
▸ BCL6 P41182 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688472 0.99 GRK6 (0.36) GRK6KDM4EALDH1A1OTUD7BUSP30
SCHEMBL32688199 0.93 HSD11B1 (0.36) ALDH1A1HPGDSMN1; SMN2NPSR1HSD11B1
SCHEMBL32688163 0.92 KISS1R (0.39) GRK6KISS1R
SCHEMBL32688425 0.91 KISS1R (0.39) ALDH1A1NPSR1KISS1RBCL6
SCHEMBL32688223 0.89 KISS1R (0.35) GRK6KDM4EALDH1A1HPGDHSD11B1
SCHEMBL32687963 0.88 USP2 (0.37) KDM4EALDH1A1HPGDSMN1; SMN2KISS1R
SCHEMBL32688274 0.87 BRD4 (0.38) GRK6KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL32688418 0.86 HSD17B10 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2KISS1R
SCHEMBL32688427 0.86 KISS1R (0.35) KDM4EALDH1A1HPGDSMN1; SMN2KISS1R
SCHEMBL32687986 0.83 KMT2A (0.39) KDM4EALDH1A1HPGDSMN1; SMN2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK GRK6 1411/4885KDM4E 3207/4885ALDH1A1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback